Shree Ganesh Remedies Ltd
BSE:540737
Shree Ganesh Remedies Ltd
BSE:540737
Price:
507.2
INR
2.14%
Market Cap:
₹6.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Shree Ganesh Remedies Ltd
BSE:540737
|
IN |
|
G
|
Global Mofy Metaverse Ltd
NASDAQ:GMM
|
CN |
|
Stride Inc
NYSE:LRN
|
US |
|
K
|
Kora Saude Participacoes SA
BOVESPA:KRSA3
|
BR |
|
Aselsan Elektronik Sanayi ve Ticaret AS
IST:ASELS.E
|
TR |
|
Sono-Tek Corp
NASDAQ:SOTK
|
US |
|
Wow World Inc
TSE:2352
|
JP |
|
Marvelous Inc
TSE:7844
|
JP |
|
Politeknik Metal Sanayi ve Ticaret AS
IST:POLTK.E
|
TR |
|
SK IE Technology Co Ltd
KRX:361610
|
KR |
|
U
|
UnitedHealth Group Inc
XETRA:UNH
|
US |
|
A
|
Aeon Mall Co Ltd
TSE:8905
|
JP |
|
Next 15 Group PLC
LSE:NFG
|
UK |
|
Qualys Inc
NASDAQ:QLYS
|
US |
|
Al Baha Investment and Development Company SJSC
SAU:4130
|
SA |
Balance Sheet
Balance Sheet Decomposition
Shree Ganesh Remedies Ltd
Shree Ganesh Remedies Ltd
Balance Sheet Decomposition is not available for
Shree Ganesh Remedies Ltd
Shree Ganesh Remedies Ltd
Balance Sheet
Shree Ganesh Remedies Ltd
Shree Ganesh Remedies Ltd
Currency: INR
| Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
27
|
85
|
10
|
23
|
35
|
39
|
50
|
163
|
100
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
25
|
4
|
100
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
27
|
85
|
10
|
23
|
35
|
39
|
25
|
159
|
0
|
|
| Short-Term Investments |
1
|
28
|
11
|
10
|
2
|
43
|
40
|
30
|
31
|
0
|
0
|
47
|
183
|
|
| Total Receivables |
49
|
39
|
60
|
70
|
109
|
117
|
143
|
221
|
187
|
274
|
350
|
230
|
242
|
|
| Accounts Receivables |
35
|
23
|
42
|
57
|
73
|
57
|
97
|
178
|
133
|
184
|
279
|
203
|
223
|
|
| Other Receivables |
14
|
16
|
18
|
14
|
36
|
59
|
46
|
43
|
54
|
90
|
70
|
26
|
20
|
|
| Inventory |
33
|
31
|
34
|
30
|
28
|
43
|
65
|
64
|
127
|
136
|
182
|
255
|
244
|
|
| Other Current Assets |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
12
|
7
|
|
| Total Current Assets |
83
|
99
|
105
|
111
|
166
|
287
|
258
|
338
|
380
|
449
|
643
|
702
|
776
|
|
| PP&E Net |
39
|
44
|
45
|
43
|
42
|
61
|
144
|
187
|
203
|
298
|
764
|
971
|
1 033
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
971
|
1 033
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
237
|
330
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
15
|
6
|
5
|
5
|
4
|
5
|
|
| Note Receivable |
2
|
2
|
2
|
0
|
3
|
4
|
7
|
11
|
15
|
0
|
0
|
20
|
90
|
|
| Long-Term Investments |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
18
|
14
|
1
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
3
|
3
|
2
|
1
|
1
|
11
|
12
|
15
|
|
| Total Assets |
124
N/A
|
145
+17%
|
153
+5%
|
157
+3%
|
211
+35%
|
356
+69%
|
413
+16%
|
553
+34%
|
606
+10%
|
770
+27%
|
1 438
+87%
|
1 709
+19%
|
1 919
+12%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
8
|
6
|
11
|
7
|
25
|
18
|
39
|
45
|
62
|
95
|
145
|
82
|
60
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
8
|
|
| Short-Term Debt |
15
|
0
|
0
|
0
|
0
|
21
|
3
|
21
|
2
|
0
|
26
|
7
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
0
|
0
|
0
|
0
|
65
|
88
|
|
| Other Current Liabilities |
11
|
20
|
10
|
8
|
20
|
26
|
24
|
38
|
38
|
56
|
66
|
28
|
6
|
|
| Total Current Liabilities |
35
|
26
|
21
|
15
|
44
|
65
|
68
|
104
|
102
|
150
|
237
|
187
|
162
|
|
| Long-Term Debt |
3
|
1
|
0
|
0
|
0
|
2
|
2
|
22
|
0
|
0
|
309
|
292
|
296
|
|
| Deferred Income Tax |
2
|
2
|
1
|
1
|
1
|
1
|
3
|
3
|
2
|
2
|
0
|
6
|
5
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
3
|
5
|
|
| Total Liabilities |
40
N/A
|
29
-28%
|
23
-18%
|
17
-28%
|
46
+176%
|
69
+50%
|
75
+8%
|
131
+74%
|
106
-19%
|
154
+46%
|
549
+256%
|
488
-11%
|
468
-4%
|
|
| Equity | ||||||||||||||
| Common Stock |
11
|
11
|
11
|
11
|
11
|
90
|
90
|
90
|
100
|
120
|
125
|
128
|
128
|
|
| Retained Earnings |
74
|
106
|
118
|
129
|
156
|
199
|
250
|
334
|
402
|
497
|
766
|
868
|
1 099
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
766
|
225
|
224
|
|
| Other Equity |
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
2
|
1
|
0
|
0
|
|
| Total Equity |
84
N/A
|
117
+38%
|
129
+11%
|
140
+8%
|
165
+18%
|
287
+74%
|
338
+18%
|
422
+25%
|
500
+18%
|
616
+23%
|
889
+44%
|
1 221
+37%
|
1 452
+19%
|
|
| Total Liabilities & Equity |
124
N/A
|
145
+17%
|
153
+5%
|
157
+3%
|
211
+35%
|
356
+69%
|
413
+16%
|
553
+34%
|
606
+10%
|
770
+27%
|
1 438
+87%
|
1 709
+19%
|
1 919
+12%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
9
|
9
|
9
|
10
|
10
|
10
|
10
|
10
|
10
|
13
|
12
|
13
|
13
|
|
Switch to:
Switch to:
See Also
Discover More
